Secondary metabolites are a heterogeneous class of chemicals that often mediate interactions between species. The tryptophan-derived secondary metabolite, psilocin, is a serotonin receptor agonist that induces altered states of consciousness. A phylogenetically disjunct group of mushroom-forming fungi in the Agaricales produce the psilocin prodrug, psilocybin. Spotty phylogenetic distributions of fungal compounds are sometimes explained by horizontal transfer of metabolic gene clusters among unrelated fungi with overlapping niches. We report the discovery of a psilocybin gene cluster in three hallucinogenic mushroom genomes, and evidence for its horizontal transfer between fungal lineages. Patterns of gene distribution and transmission suggest that synthesis of psilocybin may have provided a fitness advantage in the dung and late wood-decay fungal niches, which may serve as reservoirs of fungal indole-based metabolites that alter behavior of mycophagous and wood-eating invertebrates. These hallucinogenic mushroom genomes will serve as models in neurochemical ecology, advancing the (bio)prospecting and synthetic biology of novel neuropharmaceuticals.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121855PMC
http://dx.doi.org/10.1002/evl3.42DOI Listing

Publication Analysis

Top Keywords

hallucinogenic mushroom
12
gene cluster
8
horizontal transfer
8
mushroom genomes
8
horizontal gene
4
cluster transfer
4
transfer increased
4
increased hallucinogenic
4
mushroom diversity
4
diversity secondary
4

Similar Publications

MycoNews 2023: Editorial, news, reports, awards, personalia, and book news.

IMA Fungus

February 2024

Trait Diversity and Function, Royal Botanic Gardens, Kew, Surrey TW9 3DS UK.

This fifth annual edition of starts with an editorial on the critical importance of International Mycological Congresses (IMCs) to the health of mycology. Items on Counting down to IMC12, the State of the World's Plants and Fungi 2023, and progress towards Improving nomenclatural stability in medically important fungi follow. Reports are provided of several mycological meetings in 2023: the Asian Mycological Congress, XIX Congress of European Mycologists, a meeting of European Mycological Groups and Societies, the XI Latin American Mycological Congress, Westerdijk Spring Symposium on Fungal Evolution, the Brazilian Society of Mycology, the Annual Meeting of the Mycological Society of China, and the Fifth Iranian Mycological Congress.

View Article and Find Full Text PDF

is a genus of mushroom-forming fungi with ecological, ethnomycological, and clinical importance due to psilocybin production by most species. We present five genomes that enable deeper discovery and analysis of the psilocybin gene cluster and increase taxonomic resolution within : , nom. prov.

View Article and Find Full Text PDF

Quantitative LC-QToF-MS Analysis of Mycochemicals in Amanita muscaria, Psilocybe spp. (Agaricomycetes), and Consumer Products.

Int J Med Mushrooms

December 2024

National Center for Natural Products Research, Division of Pharmacognosy, Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA.

The psychedelic mushroom market has expanded rapidly due to changing regulations and increasing consumer demand. Product diversity now extends beyond traditional capsules and tablets to include gummies, powders, and confectionery items, complicating quality control efforts. To assess the quality and potential adulteration of Amanita musca-ria and Psilocybe cubensis-based products, a validated LC-QToF-MS method was developed.

View Article and Find Full Text PDF

Methamphetamine (MA) dependence leads to severe physical and psychological issues. Current treatments, including psychosocial therapies and residential rehabilitation, face limitations such as high relapse rates, cost, and accessibility issues. As a result, there is an urgent need for novel approaches to treat MA dependence that are effective, affordable, and accessible to patients.

View Article and Find Full Text PDF

Background: Treatment with so-called psychedelic drugs, including psilocybin, lysergic acid diethylamide (LSD), and others, is among the most promising recent developments in psychiatry. This review focuses on psilocybin, a substance found in all mushrooms of the genus Psilocybe, because the largest amount of available evidence relates to this drug.

Methods: This review is based on pertinent publications (since 1969) that were retrieved by a selective search carried out in August 2024 in the PubMed and ScienceDirect databases employing the keywords "psilocybin" AND "long-term effects" AND "mental disorders", with an emphasis on randomized, controlled clinical trials (RCTs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!